Insider trades
Gary Charles Robb, Chief Officer of Corcept Therapeutics CORT, has filed 0 purchases and 14 sales on the open market. The latest trade was on 09/24.
Gary Charles Robb
Chief Business Officer
- Company
- Corcept Therapeutics CORT
- First filing
- 23/02/15
- Trades
- 127 trades
- Buys / sales
- 0 / 14
- 12-month net buying
- No record
- Last trade
- 09/24
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 25/08/22 | 25/08/26 | 2,326 sh | $71.27 | $165,774.02 | −12.7% | |
| Open-market sale | 25/06/16 | 25/06/18 | 3,185 sh | $70.77 | $225,402.45 | −19.2% | |
| Open-market sale | 25/05/20 | 25/05/22 | 2,279 sh | $75.85 | $172,862.15 | −12.1% | |
| Open-market sale10b5-1 plan | 25/01/02 | 25/01/06 | 11,000 sh | $50.50 | $555,500 | −35.3% | |
| Open-market sale | 24/11/22 | 24/11/26 | 2,609 sh | $56.20 | $146,625.8 | −11.5% | |
| Open-market sale10b5-1 plan | 24/10/01 | 24/10/01 | 11,000 sh | $46.28 | $509,080 | −32.6% | |
| Open-market sale | 24/08/26 | 24/08/28 | 3,101 sh | $35.71 | $110,736.71 | −11.8% | |
| Open-market sale10b5-1 plan | 24/07/01 | 24/07/03 | 11,000 sh | $32.49 | $357,390 | −29.5% | |
| Open-market sale10b5-1 plan | 24/05/28 | 24/05/30 | 11,000 sh | $30.39 | $334,290 | −35.3% | |
CORT | Open-market sale | 23/12/05–23/12/06 | 23/12/06 | 7,593 sh2 trades | $26.88avg. | $204,064.99 | −26.2% |
| Open-market sale | 23/09/19 | 23/09/20 | 5,000 sh | $32.74 | $163,700 | −18.5% | |
CORT | Open-market sale | 23/05/09–23/05/10 | 23/05/11 | 44,000 sh2 trades | $23.93avg. | $1,053,080 | −68.8% |